• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

First Trust Amex Biotech Index Fund (NY:FBT)

195.45 UNCHANGED
Streaming Delayed Price Updated: 8:00 PM EDT, Mar 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 195.45
Bid (Size) 195.09 (200)
Ask (Size) 197.13 (300)
Prev. Close 195.45
Today's Range 195.45 - 195.45
52wk Range 141.38 - 224.94
Shares Outstanding 62,000
Dividend Yield 0.60%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Sarepta Shares Rise As Company Begins Enrollment In Gene Therapy Safety Enhancement Study ↗
March 16, 2026
Data from the study cohort is aimed at determining whether administering sirolimus prior to and after Elevidys infusion can help reduce risks associated with the gene therapy. 
Via Stocktwits
Topics Death
News headline image
SNSE Stock Surges To 21-Month High – Everything To Know About Its Faeth Therapeutics Acquisition ↗
February 18, 2026
The company said that the acquisition adds Faeth’s lead investigational therapy, PIKTOR, to its oncology portfolio. 
Via Stocktwits

Performance

YTD
-5.9%
-5.9%
1 Month
-6.9%
-6.9%
3 Month
-5.7%
-5.7%
6 Month
+10.5%
+10.5%
1 Year
+13.9%
+13.9%

More News

Read More
Why Did SRPT Stock Rise 6% In Pre-Market Today? ↗
January 26, 2026
Via Stocktwits
BDSX Stock Shot Up 23% Pre-Market Today — What’s Fueling The Surge? ↗
January 12, 2026
Via Stocktwits
News headline image
POET Technologies Lands $5 Million Order As AI Demand Surges ↗
October 22, 2025
Via Benzinga
Topics Artificial Intelligence
Bitcoin Drops Below $114K With XRP, Solana, Dogecoin Leading The Slide – ETF Outflows Hit $1.3B Over the Last 4 Days ↗
August 06, 2025
Via Stocktwits
Topics ETFs
News headline image
Genmab Stock Rises On Strong Darzalex Sales In Q1: Retail Remains Extremely Bullish ↗
April 15, 2025
Via Stocktwits
Topics Stocks
News headline image
Healthcare Sector Trying To Bounce Back ↗
March 09, 2025
Via Talk Markets
Topics ETFs Stocks / Equities
News headline image
Is It Time To Shift Focus To Beaten-Down Healthcare Stocks As Volatility Soars? ↗
March 04, 2025
Via Talk Markets
Topics ETFs Stocks / Equities
News headline image
NIH Funding Cuts To Spook Healthcare Stocks? RFK Jr's Confirmation At HHS Sparks Concerns Over Research Dollars, 'Causing Uncertainty,' Says Analyst ↗
February 24, 2025
Via Benzinga
News headline image
Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention ↗
April 13, 2023
Via Benzinga
News headline image
Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules ↗
April 13, 2023
Via Benzinga
News headline image
New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications ↗
April 12, 2023
Via Benzinga
News headline image
Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead ↗
April 11, 2023
Via Benzinga
News headline image
FDA Withdraws Lone Premature Birth Drug Makena Over Lack of Proven Benefits ↗
April 06, 2023
Via Benzinga
News headline image
US Judge Weighs Nationwide Ban On Abortion Pills ↗
March 16, 2023
Via Benzinga
News headline image
FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug' ↗
March 01, 2023
Via Benzinga
News headline image
Lots Of & Increasing Evidence That Stocks Are Bottoming For Now ↗
May 23, 2022
Via Talk Markets
News headline image
How do Biotechnology Funds and ETFs Perform Over Five Years? ↗
March 21, 2022
Via Talk Markets
News headline image
Biotech ETFs That Outperformed Last Week ↗
December 20, 2021
Via Talk Markets
News headline image
Biotech ETFs To Benefit From Latest Booster Update ↗
August 21, 2021
Via Talk Markets
News headline image
Q2 Growth 'Nothing Short Of Virtuous': Economist ↗
July 29, 2021
Via Benzinga
News headline image
Top-Performing Biotech ETFs of Last Week ↗
June 14, 2021
Via Talk Markets
News headline image
5 Top ETFs With Exposure To Biogen ↗
June 07, 2021
Via Talk Markets
News headline image
5 Top ETFs With Exposure To Biogen ↗
June 07, 2021
Via Benzinga

Frequently Asked Questions

Is First Trust Amex Biotech Index Fund publicly traded?
Yes, First Trust Amex Biotech Index Fund is publicly traded.
What exchange does First Trust Amex Biotech Index Fund trade on?
First Trust Amex Biotech Index Fund trades on the New York Stock Exchange
What is the ticker symbol for First Trust Amex Biotech Index Fund?
The ticker symbol for First Trust Amex Biotech Index Fund is FBT on the New York Stock Exchange
What is the current price of First Trust Amex Biotech Index Fund?
The current price of First Trust Amex Biotech Index Fund is 195.45
When was First Trust Amex Biotech Index Fund last traded?
The last trade of First Trust Amex Biotech Index Fund was at 03/17/26 08:00 PM ET
What is the market capitalization of First Trust Amex Biotech Index Fund?
The market capitalization of First Trust Amex Biotech Index Fund is 12.12M
How many shares of First Trust Amex Biotech Index Fund are outstanding?
First Trust Amex Biotech Index Fund has 12M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap